Advertisement

Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure

  • Gianfranco ParatiEmail author
  • Martino Francesco Pengo
  • Carolina Lombardi
Sleep and Hypertension (S. Justin Thomas, Section Editor)
  • 91 Downloads
Part of the following topical collections:
  1. Topical Collection on Sleep and Hypertension

Abstract

Purpose of Review

Obstructive sleep apnea (OSA) and hypertension are two phenomena deeply linked together and, although a causal relationship has been suggested, a recent meta-analysis showed only a very modest effect of OSA treatment on blood pressure (BP). However, a vast number of randomized controlled trials published so far share some limitations, mainly of methodological nature: neither OSA nor BP is always assessed in a standardized way. Moreover, compliance with OSA treatment is often sub-optimal making the results of these trials difficult to interpret.

Recent Findings

Recent studies have shown that antihypertensive drugs can reduce BP more than OSA treatment, showing a better compliance profile and very few side effects.

Summary

Considering the importance of reducing the overall cardiovascular risk of OSA patients, a more careful management of patient’s antihypertensive medication could allow a better BP control also in this condition. In addition, greater efforts should be made to improve patient’s acceptance of OSA treatment with the aim of improving their compliance.

Keywords

Obstructive sleep apnea Hypertension Blood pressure Continuous positive airway pressure Mandibular advancement device 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 2001;154(1):50–9.CrossRefGoogle Scholar
  2. 2.
    Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension. 2010;56(6):1077–82.CrossRefGoogle Scholar
  3. 3.
    Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: Joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (Cooperation in Scientific and Technological research) ACTION B26 on Obstructive Sleep Apnea. J Hypertens. 2012;30(4):633–46.CrossRefGoogle Scholar
  5. 5.
    Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir. 1972;8(5):1159–72.Google Scholar
  6. 6.
    Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med. 1976;27:465–84.CrossRefGoogle Scholar
  7. 7.
    Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169–76.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    O'Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179(12):1159–64.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Cano-Pumarega I, Duran-Cantolla J, Aizpuru F, Miranda-Serrano E, Rubio R, Martinez-Null C, et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med. 2011;184(11):1299–304.CrossRefGoogle Scholar
  10. 10.
    Bisogni V, Pengo MF, Maiolino G, Rossi GP. The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea. J Thorac Dis. 2016;8(2):243–54.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Parati G, Lombardi C, Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol. 2007;293(4):R1671–83.CrossRefGoogle Scholar
  12. 12.
    Bonsignore MR, Parati G, Insalaco G, Marrone O, Castiglioni P, Romano S, et al. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2002;166(3):279–86.CrossRefPubMedGoogle Scholar
  13. 13.
    Parati G, Di Rienzo M, Bonsignore MR, Insalaco G, Marrone O, Castiglioni P, et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens. 1997;15(12 Pt 2):1621–6.CrossRefGoogle Scholar
  14. 14.
    Iturriaga R, Oyarce MP, Dias ACR. Role of carotid body in intermittent hypoxia-related hypertension. Curr Hypertens Rep. 2017;19(5):38.CrossRefPubMedGoogle Scholar
  15. 15.
    Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep. 1987;10(1):35–44.CrossRefPubMedGoogle Scholar
  16. 16.
    Gilardini L, Lombardi C, Redaelli G, Mattaliano P, Fanari P, Cornacchia M, et al. Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines. J Hypertens. 2018;36(1):199–204.CrossRefPubMedGoogle Scholar
  17. 17.
    Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98(8):772–6.CrossRefGoogle Scholar
  18. 18.
    Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep. 1996;19(5):378–81.CrossRefPubMedGoogle Scholar
  20. 20.
    Fava C, Dorigoni S, Vedove FD, Danese E, Montagnana M, Guidi GC, et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest. 2014;145(4):762–71.CrossRefPubMedGoogle Scholar
  21. 21.
    Palmer AJ, Bulpitt CJ, Fletcher AE, Beevers DG, Coles EC, Ledingham JG, et al. Relation between blood pressure and stroke mortality. Hypertension. 1992;20(5):601–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Schwarz EI, Schlatzer C, Rossi VA, Stradling JR, Kohler M. Effect of CPAP withdrawal on BP in OSA: data from three randomized controlled trials. Chest. 2016;150(6):1202–10.CrossRefPubMedGoogle Scholar
  23. 23.
    Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep. 2004;27(5):934–41.CrossRefPubMedGoogle Scholar
  24. 24.
    Gagnadoux F, Pepin JL, Vielle B, Bironneau V, Chouet-Girard F, Launois S, et al. Impact of mandibular advancement therapy on endothelial function in severe obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS. 2017;195(no pagination).Google Scholar
  25. 25.
    Marrone O, Bonsignore MR. Blood-pressure variability in patients with obstructive sleep apnea: current perspectives. Nat Sci Sleep. 2018;10:229–42.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68.CrossRefGoogle Scholar
  27. 27.
    Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, et al. The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Eur Heart J. 2018.  https://doi.org/10.1093/eurheartj/ehy624.CrossRefGoogle Scholar
  28. 28.
    Shirasaki O, Kuwabara M, Saito M, Tagami K, Washiya S, Kario K. Development and clinical application of a new technique for detecting ‘sleep blood pressure surges’ in sleep apnea patients based on a variable desaturation threshold. Hypertens Res. 2011;34(8):922–8.CrossRefGoogle Scholar
  29. 29.
    Djavadkhani Y, Marshall NS, D'Rozario AL, Crawford MR, Yee BJ, Grunstein RR, et al. Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial. Thorax. 2015;70:265–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Martinez-Garcia MA, Capote F, Campos-Rodriguez F, Lloberes P, Diaz de Atauri MJ, Somoza M, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407–15.CrossRefGoogle Scholar
  31. 31.
    Marrone O, Salvaggio A, Bue AL, Bonanno A, Riccobono L, Insalaco G, et al. Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity. Clin Exp Hypertens. 2011;33(6):373–80.CrossRefPubMedGoogle Scholar
  32. 32.
    Marrone O, Cibella F, Pepin JL, Grote L, Verbraecken J, Saaresranta T, et al. Fixed but not autoadjusting positive airway pressure attenuates the time-dependent decline in glomerular filtration rate in patients with OSA. Chest. 2018;154(2):326–34.CrossRefPubMedGoogle Scholar
  33. 33.
    Xiao S, Bastianpillai J, Ratneswaran C, Pengo MF, Luo Y, Jolley CJ, et al. Continuous positive airway pressure and breathlessness in obese patients with obstructive sleep apnea: a pilot study. Sleep. 2016;39(6):1201–10.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ratneswaran C, Pengo MF, Xiao S, Luo Y, Rossi GP, Polkey MI, et al. The acute effect of continuous positive airway pressure titration on blood pressure in awake overweight/obese patients with obstructive sleep apnoea. Blood Press. 2018:1–9.Google Scholar
  35. 35.
    Robinson GV, Langford BA, Smith DM, Stradling JR. Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). Thorax. 2008;63(10):855–9.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Pengo MF, Drakatos P, Kosky C, Williams A, Hart N, Rossi GP, et al. Nocturnal pulse rate and symptomatic response in patients with obstructive sleep apnoea treated with continuous positive airway pressure for one year. J Thorac Dis. 2014;6(6):598–605.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Lombardi C, Parati G, Cortelli P, Provini F, Vetrugno R, Plazzi G, et al. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res. 2008;17(3):263–70.CrossRefGoogle Scholar
  38. 38.
    • Castro-Grattoni AL, Torres G, Martinez-Alonso M, Barbe F, Turino C, Sanchez-de-la-Torre A, et al. Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring. Eur Respir J. 2017;50(4). Finding predictors of BP response to CPAP is of crucial importance. In this paper, the authors showed that nocturnal hypertension, circadian BP pattern, and nighttime heart rate could be clinical predictors of BP response to CPAP. Google Scholar
  39. 39.
    • Joyeux-Faure M, Jullian-Desayes I, Pepin JL, Cracowski JL, Baguet JP, Tamisier R, et al. Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: A randomized controlled pilot study. Respirology. 2016;21(3):546–52. In this randomized controlled trial, authors tested the effect of bosentan on blood pressure in patients with OSA. They showed no significant changes in blood pressure suggesting that endothelin-1 blockade does not play a major role in treatment of OSA-related hypertension. CrossRefPubMedGoogle Scholar
  40. 40.
    Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17(1):61–6.CrossRefGoogle Scholar
  41. 41.
    Jordan W, Reinbacher A, Cohrs S, Grunewald RW, Mayer G, Ruther E, et al. Obstructive sleep apnea: plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides. 2005;26(9):1654–60.CrossRefPubMedGoogle Scholar
  42. 42.
    Pepin JL, Tamisier R, Barone-Rochette G, Launois SH, Levy P, Baguet JP. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;182(7):954–60.CrossRefPubMedGoogle Scholar
  43. 43.
    Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension. 1999;34(2):309–14.CrossRefPubMedGoogle Scholar
  44. 44.
    •• Eskandari D, Zou D, Grote L, Hoff E, Hedner J. Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med. 2018;14(3):309–17. First study assessing the effect of acetazolamide in OSA patients in a randomized controlled fashion showing that inhibition of carbonic anhydrase can not only ameliorate BP profile but also improve vascular stiffness and sleep-disordered breathing. CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Parati G, Revera M, Giuliano A, Faini A, Bilo G, Gregorini F, et al. Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. Eur Heart J. 2013;34(10):759–66.CrossRefPubMedGoogle Scholar
  46. 46.
    Sanchez-de-la-Torre M, Khalyfa A, Sanchez-de-la-Torre A, Martinez-Alonso M, Martinez-Garcia MA, Barcelo A, et al. Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment. J Am Coll Cardiol. 2015;66(9):1023–32.CrossRefGoogle Scholar
  47. 47.
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk--overview and meta-analyses of randomized trials. J Hypertens. 2014;32(12):2305–14.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Gianfranco Parati
    • 1
    • 2
    Email author
  • Martino Francesco Pengo
    • 1
  • Carolina Lombardi
    • 1
    • 2
  1. 1.Sleep Disorder Centre, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca HospitalIRCCS Istituto Auxologico ItalianoMilanItaly
  2. 2.Department of Medicine and SurgeryUniversity of Milano-BicoccaMilanItaly

Personalised recommendations